HNF4G increases cisplatin resistance in lung adenocarcinoma via the MAPK6/Akt pathway
Background Lung adenocarcinoma is one of the most common tumors, and cisplatin is frequently used in treating lung adenocarcinoma patients. This study aimed to look into the roles and mechanisms of HNF4G in cisplatin resistance of lung adenocarcinoma. Materials & Methods Cisplatin resistance and...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
PeerJ Inc.
2023-03-01
|
| 叢編: | PeerJ |
| 主題: | |
| 在線閱讀: | https://peerj.com/articles/14996.pdf |